NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia
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in patients with AML at complete remission. The curves are estimates of population density distribution. The dashed line represents the threshold used in the rest of the study. The black line represents the limit of statistical significance (P < 0.05). The normality of distributions were evaluated with a d'Agostino-Pearson normality test.
